- Home
- NTRA vs FITB Comparison
NTRA vs FITB Comparison
Compare NTRA & FITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRA
- FITB
- Stock Information
- Founded
- NTRA 2003
- FITB 1858
- Country
- NTRA United States
- FITB United States
- Employees
- NTRA N/A
- FITB N/A
- Industry
- NTRA Medical Specialities
- FITB Major Banks
- Sector
- NTRA Health Care
- FITB Finance
- Exchange
- NTRA Nasdaq
- FITB Nasdaq
- Market Cap
- NTRA 27.0B
- FITB 29.9B
- IPO Year
- NTRA 2015
- FITB N/A
- Fundamental
- Price
- NTRA $238.04
- FITB $43.34
- Analyst Decision
- NTRA Strong Buy
- FITB Buy
- Analyst Count
- NTRA 16
- FITB 16
- Target Price
- NTRA $224.88
- FITB $49.94
- AVG Volume (30 Days)
- NTRA 1.8M
- FITB 6.9M
- Earning Date
- NTRA 11-06-2025
- FITB 10-17-2025
- Dividend Yield
- NTRA N/A
- FITB 3.70%
- EPS Growth
- NTRA N/A
- FITB 11.70
- EPS
- NTRA N/A
- FITB 3.35
- Revenue
- NTRA $2,116,676,000.00
- FITB $8,125,000,000.00
- Revenue This Year
- NTRA $25.70
- FITB $15.99
- Revenue Next Year
- NTRA $15.42
- FITB $27.84
- P/E Ratio
- NTRA N/A
- FITB $12.92
- Revenue Growth
- NTRA 38.17
- FITB 0.77
- 52 Week Low
- NTRA $125.38
- FITB $32.25
- 52 Week High
- NTRA $240.40
- FITB $49.07
- Technical
- Relative Strength Index (RSI)
- NTRA 82.14
- FITB 57.29
- Support Level
- NTRA $195.14
- FITB $40.68
- Resistance Level
- NTRA $212.21
- FITB $42.71
- Average True Range (ATR)
- NTRA 9.35
- FITB 0.92
- MACD
- NTRA 2.78
- FITB 0.11
- Stochastic Oscillator
- NTRA 96.00
- FITB 87.13
About NTRA Natera Inc.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
About FITB Fifth Third Bancorp
Fifth Third Bancorp is a diversified financial-services company headquartered in Cincinnati. The company has over $210 billion in assets and operates numerous full-service banking branches and ATMs throughout Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, and North Carolina.